Article Information
History
- May 20, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Jacob D. Galson1,*,
- Sebastian Schaetzle1,
- Rachael J. M. Bashford-Rogers1,2,
- Matthew I. J. Raybould3,
- Aleksandr Kovaltsuk3,
- Gavin J. Kilpatrick1,
- Ralph Minter1,
- Donna K. Finch1,
- Jorge Dias1,
- Louisa James4,
- Gavin Thomas4,
- Wing-Yiu Jason Lee4,
- Jason Betley5,
- Olivia Cavlan1,
- Alex Leech1,
- Charlotte M. Deane3,
- Joan Seoane6,
- Carlos Caldas7,
- Dan Pennington4,
- Paul Pfeffer4 and
- Jane Osbourn1,*
- 1Alchemab Therapeutics Ltd, 55-56 Russell Square, London, WC1B 4HP, UK
- 2Wellcome Centre for Human Genetics, Roosevelt Dr, Oxford, OX3 7BN, UK
- 3Oxford Protein Informatics Group, Department of Statistics, University of Oxford, Oxford OX1 3LB, UK
- 4Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AD, UK
- 5Illumina, Inc., Illumina Centre, Granta Park, Cambridge CB21 6DF, UK
- 6Translational Research Program, Vall d’Hebron Institute of Oncology, Barcelona 08035, Spain
- 7Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK
- ↵*Corresponding authors: jake{at}alchemab.com, jane{at}alchemab.com